Record Information
Version1.0
Creation Date2019-07-14 16:37:13 UTC
Last Updated2019-10-01 21:41:35 UTC
CypComp IDCC02168
Compound Information
NameBupivacaine
Structure ImageLebvlxferqhonn inizcteosa n
InChIKeyLEBVLXFERQHONN-INIZCTEOSA-N
PubChem ID92253
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <4,5;Cleavage;R1>
  • <4,H;Oxidation;R1>
  • <4,5;Cleavage;R1>
  • <4,H;Oxidation;R1>
  • Not Available
  • <4,5;Cleavage;R1>
  • <4,H;Oxidation;R1>
References
  1. Gantenbein M, Attolini L, Bruguerolle B, Villard PH, Puyoou F, Durand A, Lacarelle B, Hardwigsen J, Le-Treut YP: Oxidative metabolism of bupivacaine into pipecolylxylidine in humans is mainly catalyzed by CYP3A. Drug Metab Dispos. 2000 Apr;28(4):383-5. [PubMed:10725304 ]
Download FileCC02168.sdf